Ketorolaco Trometamol Qualigen (Ketorolac Trometamol)

Ketorolac Trometamol is an NSAID used to control pain through inhibition of prostaglandin synthesis.

• Moderate to severe acute pain: provides rapid analgesia for intense pain episodes.
• Post‑operative pain: reduces pain and inflammation after surgical procedures.
• Short‑term pain management: offers effective relief for brief periods of pain when other agents are insufficient.

• Ketorolac Trometamol exerts its effect by non‑selectively inhibiting cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes. This blockade decreases the conversion of arachidonic acid to prostaglandins, leading to reduced inflammation, lowered peripheral sensitization, and diminished perception of pain at the site of injury.

Ketorolac Trometamol may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Gastrointestinal discomfort or dyspepsia.
• Nausea or vomiting.
• Headache.
• Dizziness or vertigo.
• Transient renal function changes.
• Mild skin rash.

Serious or Rare Side Effects

• Gastrointestinal bleeding or ulcer perforation.
• Severe renal impairment or failure.
• Cardiovascular thrombotic events (e.g., myocardial infarction, stroke).
• Anaphylactic or severe hypersensitivity reactions.
• Hepatotoxicity with elevated liver enzymes.

Before prescribing Ketorolac Trometamol, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

• Assess renal function: avoid in patients with severe renal impairment.
• Evaluate gastrointestinal risk: use cautiously in those with a history of ulcers or bleeding.
• Avoid in active ulcer disease or gastrointestinal perforation.
• Use the lowest effective dose for the shortest duration needed.
• Do not combine with other NSAIDs, anticoagulants, or drugs that increase bleeding risk.
• Pregnancy and lactation: safety not established; avoid unless clearly needed.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ketorolac Trometamol can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Other NSAIDs or aspirin: additive gastrointestinal toxicity.
• ACE inhibitors or ARBs: heightened risk of renal impairment.
• Lithium: elevated lithium levels leading to toxicity.
• Methotrexate: reduced clearance and possible toxicity.

Moderate Interactions (Monitor Closely)

• Selective serotonin reuptake inhibitors (SSRIs): modestly increased bleeding risk.
• Diuretics: potential for reduced renal perfusion.
• Corticosteroids: enhanced gastrointestinal ulcer risk.
• Antihypertensives: possible attenuation of blood pressure control.
• Oral hypoglycemics: may affect glucose control.